Development and validation of a prognostic model for leflunomide discontinuation with abnormal blood tests during long-term treatment: cohort study using data from the Clinical Practice Research Datalink Gold and Aurum

OBJECTIVE: To develop and validate a prognostic model for LEF discontinuation with abnormal blood test results. METHODS: Data from the Clinical Practice Research Datalink Gold and Aurum were used for model development and external validation, respectively. Participants prescribed LEF between 1 Janua...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakafero, Georgina, Grainge, Matthew J, Card, Tim, Taal, Maarten W, Aithal, Guruprasad P, Zhang, Weiya, Doherty, Michael, Fox, Christopher P, Mallen, Christian D, Abhishek, Abhishek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258529/
https://www.ncbi.nlm.nih.gov/pubmed/34718430
http://dx.doi.org/10.1093/rheumatology/keab790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258529/
https://www.ncbi.nlm.nih.gov/pubmed/34718430
http://dx.doi.org/10.1093/rheumatology/keab790

Ejemplares similares